A
Armando Ialenti
Researcher at University of Naples Federico II
Publications - 96
Citations - 4532
Armando Ialenti is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Inflammation & Neointima. The author has an hindex of 32, co-authored 91 publications receiving 4187 citations. Previous affiliations of Armando Ialenti include Western Infirmary.
Papers
More filters
Journal ArticleDOI
Modulation of acute inflammation by endogenous nitric oxide.
TL;DR: It is suggested that endogenous NO is released at the site of acute inflammation and modulates oedema formation and is predominantly generated by the constitutive or by the inducible NO synthase.
Journal Article
Anti-Inflammatory Activity of Macrolide Antibiotics
Angela Ianaro,Armando Ialenti,Pasquale Maffia,Lidia Sautebin,Laura Rombolà,Rosa Carnuccio,Teresa Iuvone,Fulvio D'Acquisto,M. Di Rosa +8 more
TL;DR: The present study shows that macrolide antibiotics have anti-inflammatory activity, which likely depends on their ability to prevent the production of proinflammatory mediators and cytokines, and suggests that these agents, particularly roxithromycin, can exert therapeutic effects independently of their antibacterial activity.
Journal ArticleDOI
Modulation of adjuvant arthritis by endogenous nitric oxide
TL;DR: The results suggest that endogenous NO modulates adjuvant arthritis, possibly by interfering with the activation of T‐lymphocytes and/or macrophages.
Journal ArticleDOI
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract.
Francesca Borrelli,Pasquale Maffia,Luisa Pinto,Angela Ianaro,Alessandra Russo,Francesco Capasso,Armando Ialenti +6 more
TL;DR: Results suggest that the anti-inflammatory activity of propolis is due to CAPE, and EPE without CAPE and galangin did not exhibit anti- inflammation effects in acute and chronic inflammation.
Journal ArticleDOI
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation
Salvatore Cuzzocrea,Barbara Pisano,Laura Dugo,Angela Ianaro,Pasquale Maffia,Nimesh S. A. Patel,Rosanna Di Paola,Armando Ialenti,Tiziana Genovese,Prabal K. Chatterjee,Massimo Di Rosa,Achille P. Caputi,Christoph Thiemermann +12 more
TL;DR: It is proposed that rosiglitazone and other potent PPAR-gamma agonists may be useful in the therapy of inflammation.